Closed amapeters closed 7 years ago
From Duke
Please find attached Duke’s current top 20 list of candidate targets, including annotations for how we got to these proteins and why we think that they may be important regulators of AD pathogenesis.
If there is anything else you need or if you have any questions, please let me know.
Best, Matthias
From MSSM
Mette,
We have just updated the target list. Attached is a list of top 50 drivers. We will upload the network models accordingly.
Bin
No new targets from UFL-ISB-Mayo:https://github.com/Sage-Bionetworks/ampadknowledgeportal/issues/167
We need to enforce standards for the provided files. Took an hour to reformat (not uniform across the submitted files).
Hi Suzana,
Sorry, just reviewed the earlier email. Here are the genes in the spreadsheet. No change to model system spreadsheet. the list is the same as the one sent earlier today. I added the annotation.
Cheers,
@kdaily - I think we need to reformat ourselves - it will take to long to go back to the groups and request new files
The layout is workable, but no one follows it. They put links and text in the gene fields, no one fills out the ensembl gene id column, etc.
I know. Cats. Herding - lesson learned, next time use a form
On Mon, Apr 17, 2017 at 10:05 AM, Kenneth Daily notifications@github.com wrote:
The layout is workable, but no one follows it. They put links and text in the gene fields, no one fills out the ensembl gene id column, etc.
— You are receiving this because you were assigned. Reply to this email directly, view it on GitHub https://github.com/Sage-Bionetworks/WallOfTargets/issues/65#issuecomment-294529889, or mute the thread https://github.com/notifications/unsubscribe-auth/ACiXB4fJkKukX4_Tx2tFCnY_RJIVe3H4ks5rw5v1gaJpZM4Mb9RO .
--
Mette A. Peters, PhD. Sage Bionetworks | 1100 Fairview Ave. North, M1-C108, Seattle, WA. 98109 mette.peters@sagebase.org | (206) 667-2113
From Emory Emory-AMPAD Candidate Targets 3.17.xlsx
Here is the updated Emory list with the Ensembl IDs for the targets. We have reviewed our nominated targets and the experimental models and we don’t have any updates right now; we are in process of working through the first consensus proteomics networks and we plan to use that info to refine our target nominations.
Best, Allan